The U.S. Meals and Drug Administration (FDA) has granted breakthrough remedy designation (BTD) for sonrotoclax, a next-generation and probably best-in-class investigational BCL2 inhibitor, for...
Throughout Breast Most cancers Consciousness Month, Dr. Komal Jhaveri, a breast medical oncologist and early drug growth specialist at Memorial Sloan Kettering...
Dr. Evan Garfein, chief of plastic and reconstructive surgical procedure at Montefiore, shares how 3D printing and tissue-engineered applied sciences could improve...
